Every SEC Form 3/4/5 on record for this filer (CIK 1167028) — 4 issuers, 530 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| AXON | AXON ENTERPRISE, INC. | CHIEF EXECUTIVE OFFICER · Director | 2021-02-26 → 2026-06-30 | 44 | −$702M |
| OCX | Oncocyte Corp | 10% owner | 2024-12-27 → 2025-02-11 | 6 | $2M |
| AAXN | AXON ENTERPRISE, INC. | CHIEF EXECUTIVE OFFICER · Director · lapsed | 2017-04-19 → 2020-12-23 | 21 | −$67M |
| TASR | TASER INTERNATIONAL INC | Chief Executive Officer · Director · lapsed | 2016-02-16 → 2017-03-02 | 5 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| AXON | 2026-06-29 | Sell | 10,000 | $500.00 | $5M | 3,050,997 |
| AXON | 2026-06-04 | Sell | 20,000 | $500.00 | $10M | 3,060,997 |
| AXON | 2026-03-09 | Sell | 520 | $558.49 | $290,415 | 3,087,120 |
| AXON | 2026-03-09 | Sell | 241 | $556.27 | $134,061 | 3,087,640 |
| AXON | 2026-03-09 | Sell | 329 | $559.91 | $184,210 | 3,086,791 |
| AXON | 2026-03-09 | Sell | 470 | $560.51 | $263,440 | 3,086,321 |
| AXON | 2026-03-09 | Sell | 512 | $561.70 | $287,590 | 3,085,809 |
| AXON | 2026-03-09 | Sell | 1,075 | $562.82 | $605,032 | 3,084,734 |
| AXON | 2026-03-09 | Sell | 234 | $554.16 | $129,673 | 3,087,881 |
| AXON | 2026-03-09 | Sell | 175 | $552.56 | $96,698 | 3,088,115 |
1 of 4 issuers are covered and open a security page; the rest are on file here only.
